Register to leave comments

  • News bot March 12, 2026, 8:08 p.m.

    📋 INSULET CORPORATION (PODD) - Clinical Trial Update

    Filing Date: 2026-03-12

    Accepted: 2026-03-12 16:06:56

    Event Type: Clinical Trial Update

    Event Details:

    INSULET CORPORATION (PODD) Announces Clinical Trial Update INSULET CORPORATION (PODD) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: distributed, tear
    • Collaboration: cost•All

    🔬 Clinical Development Pipeline (INSULET CORPORATION):

    Product Type Development Stage Therapeutic Area Source
    Omnipod M system DEVICE Approved Diabetes Mellitus ClinicalTrials.gov
    Multiple daily injections of insulin DRUG Approved Type 1 Diabetes ClinicalTrials.gov
    Omnipod 5 DEVICE Approved Type 1 Diabetes ClinicalTrials.gov
    Active Comparator: Omnipod M System with higher starting dose DEVICE Approved Type 2 Diabetes Mellitus ClinicalTrials.gov
    Active Comparator: Omnipod M System with lower starting dose DEVICE Approved Type 2 Diabetes Mellitus ClinicalTrials.gov
    Omnipod 5 SA2.0 System DEVICE Approved Diabetes Mellitus ClinicalTrials.gov
    Omnipod 5 System DEVICE Approved Diabetes Mellitus, Type 1, Type 2 ClinicalTrials.gov
    Omnipod 5 SmartAdjust 2.0 System DEVICE Approved Diabetes Mellitus, Type 1, Type 2 ClinicalTrials.gov
    Omnipod 5 Automated Glucose Control System DEVICE Approved Type2 Diabetes ClinicalTrials.gov
    Open Loop DEVICE Approved Type 1 Diabetes Mellitus ClinicalTrials.gov
    Closed Loop Control (CLC) DEVICE Approved Type 1 Diabetes Mellitus ClinicalTrials.gov
    Insulet AP (artificial pancreas) System DEVICE Approved Type 1 Diabetes Mellitus ClinicalTrials.gov
    Exercise strategies OTHER Approved Type 1 Diabetes ClinicalTrials.gov
    MDI OTHER Preclinical Diabetes Mellitus, Type 1 ClinicalTrials.gov
    Omnipod DEVICE Preclinical Diabetes Mellitus, Type 1 ClinicalTrials.gov
    Insulet automated glucose control system DEVICE Approved Type1 Diabetes Mellitus ClinicalTrials.gov
    Insulet Artificial Pancreas (AP) System DEVICE Approved Type 1 Diabetes ClinicalTrials.gov
    Omnipod Horizon™ Automated Glucose Control System DEVICE Approved Type 1 Diabetes ClinicalTrials.gov
    The Omnipod 5/Horizon HCL system DEVICE Approved Diabetes Mellitus ClinicalTrials.gov
    Omnipod 5 Automated Insulin Delivery System DEVICE Approved Type 2 Diabetes Mellitus ClinicalTrials.gov

    💼 Business Developments:

    No business developments data available.

    Structured Data:

    • Company Name: INSULET CORPORATION
    • Ticker Symbol: PODD